ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,04 (-0,65%)
2026-06-03
AKTIENPREIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership376,120 shares
Latest Disclosed Value $ 744,718
Alliancebernstein L.p. reports 7.31% increase in ownership of 26CA / ImmunityBio, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 376,120 shares of ImmunityBio, Inc. (DE:26CA) valued at $2,467,347 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 350,490 shares of ImmunityBio, Inc.. This represents a change in shares of 7.31% during the quarter. The current value of the position is $2,305,616 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM 45256X103 376,120 25,630 7.31 745 7.36 0.0002
2026-02-17 2025-12-31 13F IMMUNITYBIO COM 45256X103 350,490 -8,674 -2.42 694 -21.52 0.0002
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 359,164 7,289 2.07 884 -4.85 0.0003
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 351,875 137,845 64.40 929 44.10 0.0003
2025-05-15 2025-03-31 13F IMMUNITYBIO COM 45256X103 214,030 0 0.00 644 17.73 0.0002
2025-02-12 2024-12-31 13F IMMUNITYBIO COM 45256X103 214,030 8,500 4.14 548 -28.40 0.0002
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 205,530 0 0.00 765 -41.14 0.0003
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 205,530 26,600 14.87 1,299 35.21 0.0005
2024-05-14 2024-03-31 13F IMMUNITYBIO COM 45256X103 178,930 -106,000 -37.20 961 -32.87 0.0003
2024-02-14 2023-12-31 13F IMMUNITYBIO COM 45256X103 284,930 -10,430 -3.53 1,430 186.57 0.0006
2023-11-14 2023-09-30 13F IMMUNITYBIO COM 45256X103 295,360 -3,650 -1.22 499 -39.95 0.0002
2023-08-15 2023-06-30 13F IMMUNITYBIO COM 45256X103 299,010 47,452 18.86 831 81.84 0.0003
2023-05-15 2023-03-31 13F IMMUNITYBIO COM 45256X103 251,558 25,800 11.43 458 -60.05 0.0002
2023-02-15 2022-12-31 13F IMMUNITYBIO COM 45256X103 225,758 0 0.00 1,145 1.96 0.0005
2022-11-15 2022-09-30 13F IMMUNITYBIO COM 45256X103 225,758 0 0.00 1,122 33.57 0.0005
2022-08-15 2022-06-30 13F IMMUNITYBIO COM 45256X103 225,758 39,700 21.34 840 -19.54 0.0004
2022-05-13 2022-03-31 13F IMMUNITYBIO COM 45256X103 186,058 35,500 23.58 1,044 14.10 0.0004
2022-02-14 2021-12-31 13F IMMUNITYBIO COM 45256X103 150,558 57,058 61.02 915 0.44 0.0003
2021-11-10 2021-09-30 13F IMMUNITYBIO COM 45256X103 93,500 -6,900 -6.87 911 -36.47 0.0004
2021-07-30 2021-06-30 13F IMMUNITYBIO COM 45256X103 100,400 54,600 119.21 1,434 31.92 0.0006
2021-05-06 2021-03-31 13F IMMUNITYBIO COM 45256X103 45,800 -2,300 -4.78 1,087 69.58 0.0005
2021-02-08 2020-12-31 13F NANTKWEST COM 63016Q102 48,100 -7,400 -13.33 641 66.49 0.0003
2020-11-12 2020-09-30 13F NANTKWEST COM 63016Q102 55,500 -8,400 -13.15 385 -50.96 0.0002
2020-08-13 2020-06-30 13F NANTKWEST COM 63016Q102 63,900 63,900 785 0.0005
2019-08-13 2019-06-30 13F NANTKWEST COM 63016Q102 0 -46,100 -100.00 0 -100.00
2019-05-14 2019-03-31 13F NANTKWEST COM 63016Q102 46,100 -5,900 -11.35 73 21.67 0.0000
2019-02-13 2018-12-31 13F NANTKWEST COM 63016Q102 52,000 -12,900 -19.88 60 -75.00 0.0000
2018-11-08 2018-09-30 13F NANTKWEST COM 63016Q102 64,900 1,000 1.56 240 22.45 0.0002
2018-08-13 2018-06-30 13F NANTKWEST COM 63016Q102 63,900 3,200 5.27 196 -16.95 0.0001
2018-05-14 2018-03-31 13F NANTKWEST COM 63016Q102 60,700 5,700 10.36 236 -4.45 0.0002
2018-02-13 2017-12-31 13F NANTKWEST COM 63016Q102 55,000 0 0.00 247 -17.94 0.0002
2017-11-13 2017-09-30 13F NANTKWEST COM 63016Q102 55,000 0 0.00 301 -27.82 0.0002
2017-08-10 2017-06-30 13F NANTKWEST COM 63016Q102 55,000 21,200 62.72 417 247.50 0.0003
2017-05-11 2017-03-31 13F NANTKWEST COM 63016Q102 33,800 2,700 8.68 120 -32.58 0.0001
2017-02-13 2016-12-31 13F NANTKWEST COM 63016Q102 31,100 0 0.00 178 -26.45 0.0001
2016-11-10 2016-09-30 13F NANTKWEST COM 63016Q102 31,100 2,500 8.74 242 35.96 0.0002
2016-08-11 2016-06-30 13F NANTKWEST COM 63016Q102 28,600 18,400 180.39 178 111.90 0.0002
2016-05-13 2016-03-31 13F NANTKWEST COM 63016Q102 10,200 0 0.00 84 -52.54 0.0001
2016-02-16 2015-12-31 13F/A-1 NANTKWEST COM 63016Q102 10,200 10,200 177 0.0002
2016-02-12 2015-12-31 13F NANTKWEST COM 63016Q102 10,200 177
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.